文献速递神经肌肉病

让运动神经元呼吸:无创机械通气减缓肌萎缩侧索硬化疾病进展

Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis.
PubMed 文献 · Ann Neurol · 2024-01-29

该回顾性观察研究纳入意大利都灵ALS中心448例接受无创机械通气的ALS患者,以ALSFRS-R非呼吸项评估功能下降。无创机械通气启动后功能下降减缓(平均改善0.16分/月,95%CI 0.12-0.19,p<0.001),且在PRO-ACT数据集重复验证,夜间呼吸支持获益尤为突出。

要点

  • 无创机械通气启动后ALSFRS-R非呼吸项功能下降减缓,平均改善0.16分/月(95%CI 0.12-0.19,p<0.001)。
  • 获益不受性别、诊断年龄、NIMV前病程、起病部位及疾病严重程度影响,且非剂量依赖,夜间呼吸支持尤为突出。
  • 研究提示所有ALS患者应及时启动无创机械通气,并在临床试验结局评估中考虑NIMV对疾病进展的减缓作用。

核心结论

  • 无创机械通气显著影响ALS运动进展速率,且该效应并非由ALSFRS-R轨迹的非线性决定。
  • NIMV启动后功能下降减缓,独立于起病部位或NIMV启动时的疾病严重程度。
  • 作者认为研究结果强调所有ALS患者及时启动NIMV的重要性,并提示在评估临床试验结局时需考虑NIMV诱导的疾病进展减缓。

研究设计与样本

  • 回顾性观察研究,纳入意大利都灵ALS中心随访的448例病程中接受NIMV的ALS患者。
  • 主要结局为调整协变量后NIMV启动前后功能下降的变化,功能下降基于ALSFRS-R非呼吸项。
  • 结果在PRO-ACT(Pooled Resource Open-Access ALS Clinical Trials)数据集重复验证。

主要发现

  • NIMV启动后功能下降减缓,平均改善0.16分/月(95%CI 0.12-0.19,p<0.001)。
  • 该效应在性别、诊断年龄、NIMV启动前病程等人口学因素各亚组中一致。
  • NIMV对ALSFRS-R进展的有利影响独立于疾病分期。
  • NIMV获益非剂量依赖,夜间呼吸支持尤为突出。

临床怎么用

  • 作者认为所有ALS患者应及时启动无创机械通气。
  • 作者提示在评估临床试验结局时需考虑NIMV诱导的疾病进展减缓。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Noninvasive mechanical ventilation (NIMV) improves amyotrophic lateral sclerosis (ALS) quality of life and survival. However, data about its effect on disease progression are still lacking. Here, we test whether NIMV use changed the rate of functional decline among ALS patients. METHODS: In this retrospective observational study, we included 448 ALS patients followed up at the ALS Center in Turin, Italy, who underwent NIMV during the disease course. The primary outcome was the change in functional decline after NIMV initiation adjusting for covariates. Functional decline was based on the nonrespiratory items of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). RESULTS: NIMV initiation resulted in a slower functional decline (mean improvement = 0.16 points per month, 95% confidence interval = 0.12-0.19, p < 0.001), with consistent effects observed across various demographic factors, including sex, age at diagnosis, and disease duration before NIMV initiation. This finding was replicated using the PRO-ACT (Pooled Resource Open-Access ALS Clinical Trials) dataset. The favorable impact of NIMV on ALSFRS-R progression was evident independently of disease stages. Notably, NIMV benefits were not dose-dependent but were particularly prominent for nighttime respiratory support. INTERPRETATION: NIMV significantly influences the rate of motor progression in ALS, and this effect is not determined by the nonlinearity of ALSFRS-R trajectory. The functional decline slowed following NIMV initiation, independently of the site of disease onset or disease severity at the time of NIMV initiation. Our findings underscore the importance of timely NIMV initiation for all ALS patients and highlight the need to consider NIMV-induced slowing of disease progression when evaluating clinical trial outcomes. ANN NEUROL 2024;95:817-822.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Grassano M, Koumantakis E, Manera U, et al. Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis. Ann Neurol. 2024. PMID: 38284771. doi:10.1002/ana.26875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。